Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and DevelopmentISBN: 978-0-471-77001-5
Hardcover
392 pages
October 2006
|
ANA MARTINEZ is the Research and Development Director for
NeuroPharma. She has been and still is an active researcher in the
design and synthesis of GSK-3 inhibitors.
ANA CASTRO is the Medicinal Chemistry Director of NeuroPharma. She was formerly a tenured scientist at the Medicinal Chemistry Institute.
MIGUEL MEDINA is the Drug Discovery Director at NeuroPharma. He was formerly an instructor at the Brigham and Women's Hospital and the Harvard Medical School.